You got in at a way better price than me— I've bought and held since January and... that has not gone well. But I continue to hold because I believe the tech is a better way to do things.

DermTech $DMTK is a molecular diagnostics company that develops and markets non-invasive diagnostic tests to diagnose skin cancer and other skin related conditions. The company offers a Pigmented Lesion Assay, which is a gene expression test that helps rule out melanoma and the need for a surgical biopsy.